FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshinobu Manome

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Procedures

Genetic Therapy

Physiology

Transfection

Co-author Network

Publications

TOP 3
Kouki Fujioka; Keiichi Ikeda; Jun-ichi Kita; Yoshinobu Manome; Yoshihiro Aoyama; Eiji Arakawa; Kenji Yamamoto
Detection of Aeromonas hydrophila in liquid media by volatile production similarity patterns, using a FF-2A electronic nose.
Minori Kamada; Katsuyoshi Tojo; Kenji Yamamoto; Noibutake Akiyama; Kouhei Akiyoshi; Kouki Fujioka; Sanshiro Hanada; Keiichi Ikeda; Yuriko Inoue; Yoshinobu Manome
Expression of mRNAs of urocortin and corticotropin-releasing factor receptors in malignant glioma cell lines.
Keiichi Ikeda; Tsuyoshi Isaka; Yoshinobu Manome; Kouki Fujioka; Katsuyoshi Tojo
Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshinobu Manome (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kouki Fujioka; Keiichi Ikeda; Jun-ichi Kita; Yoshinobu Manome; Yoshihiro Aoyama; Eiji Arakawa; Kenji Yamamoto
Detection of Aeromonas hydrophila in liquid media by volatile production similarity patterns, using a FF-2A electronic nose.
Sensors (Basel, Switzerland) 2013;13(1):736-45.
2012: Minori Kamada; Katsuyoshi Tojo; Kenji Yamamoto; Noibutake Akiyama; Kouhei Akiyoshi; Kouki Fujioka; Sanshiro Hanada; Keiichi Ikeda; Yuriko Inoue; Yoshinobu Manome
Expression of mRNAs of urocortin and corticotropin-releasing factor receptors in malignant glioma cell lines.
Anticancer research 2012;32(12):5299-307.
2012: Keiichi Ikeda; Tsuyoshi Isaka; Yoshinobu Manome; Kouki Fujioka; Katsuyoshi Tojo
Suppression of aldosterone synthesis and secretion by ca(2+) channel antagonists.
International journal of endocrinology 2012;2012():519467.
2012: Naotake Funamizu; Kenei Furukawa; Curtis Ray Lacy; Takeyuki Misawa; Katsuhiko Yanaga; Kaori Fujita; Yoshinobu Manome
Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.
PloS one 2012;7(5):e37424.
2012: Keiichi Ikeda; Yoshinobu Manome; Kouki Fujioka; Katsuyoshi Tojo
Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease.
International journal of endocrinology 2012;2012():198628.
2012: Kouki Fujioka; Keiichi Ikeda; Nobuo Ito; Takeo Iwamoto; Satoshi Kakishima; Yoshinobu Manome; Tomohiro Minami; Jin Murata; Fumio Shimozono; Mika Shirasu; Tadashi Tominaga; Kenji Yamamoto; Yasuko Tomizawa
Objective display and discrimination of floral odors from Amorphophallus titanum, bloomed on different dates and at different locations, using an electronic nose.
Sensors (Basel, Switzerland) 2012;12(2):2152-61.
2011: Keisuke Sato; Hiroaki Sukegawa; Yasunori Takigami; Shinobu Yokosuka; Kouki Fujioka; Kenji Hirakuri; Hideo Iwai; Yoshinobu Manome; Naoki Fukata
Size-tunable silicon/iron oxide hybrid nanoparticles with fluorescence, superparamagnetism, and biocompatibility.
Journal of the American Chemical Society 2011;133(46):18626-33.
2011: Hiroshi Takeyama; Shigeya Kyoda; Tomoyoshi Okamoto; Yoshinobu Manome; Michiko Watanabe; Satoki Kinoshita; Ken Uchida; Atsuhiko Sakamoto; Toshiaki Morikawa
The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.
Anticancer research 2011;31(4):1395-8.
2010: Akiyoshi Hoshino; Tadahiro Iimura; Satoshi Ueha; Sanshiro Hanada; Yutaka Maruoka; Mitsuori Mayahara; Keiko Suzuki; Toshio Imai; Masako Ito; Yoshinobu Manome; Masato Yasuhara; Takaaki Kirino; Akira Yamaguchi; Kouji Matsushima; Kenji Yamamoto
Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.
The Journal of biological chemistry 2010;285(37):28826-37.
2010: Yuika Sakurai; Rie Suzuki; Ryuichi Yoshida; Hiromi Kojima; Michiko Watanabe; Yoshinobu Manome; Toya Ohashi; Yoshikatu Eto; Hiroshi Moriyama
Inner ear pathology of alpha-galactosidase A deficient mice, a model of Fabry disease.
Auris, nasus, larynx 2010;37(3):274-80.
2010: Yoshinobu Manome; Shuichi Mizuno; Nobutake Akiyama; Kouki Fujioka; Hideki Saito; Yoshiaki Hataba; Toshiaki Kobayashi; Michiko Watanabe
Three-dimensional cell culture of glioma and morphological comparison of four different human cell lines.
Anticancer research 2010;30(2):383-9.
2010: Naotake Funamizu; Aikou Okamoto; Yuko Kamata; Takeyuki Misawa; Tadashi Uwagawa; Takeshi Gocho; Katsuhiko Yanaga; Yoshinobu Manome
Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase?
Oncology reports 2010;23(2):471-5.
2009: Kouki Fujioka; Yasuhiro Futamura; Tomoo Shiohara; Akiyoshi Hoshino; Fumihide Kanaya; Yoshinobu Manome; Kenji Yamamoto
Amino acid synthesis in a supercritical carbon dioxide - water system.
International journal of molecular sciences 2009;10(6):2722-32.
2009: Kouki Fujioka; Eiji Arakawa; Jun-ichi Kita; Yoshihiro Aoyama; Toshiro Okuda; Yoshinobu Manome; Kenji Yamamoto
Combination of real-value smell and metaphor expression aids yeast detection.
PloS one 2009;4(11):e7939.
2009: Yoshinobu Manome; Hiroshi Furuhata; Akifumi Hashimoto; Naotake Funamizu; Rie Suzuki; Sho Ishizawa; Nobutake Akiyama; Toshiaki Kobayashi; Michiko Watanabe
Application of therapeutic insonation to malignant glioma cells and facilitation by echo-contrast microbubbles of levovist.
Anticancer research 2009;29(1):235-42.
2008: Kouki Fujioka; Sanshiro Hanada; Kenji Hirakuri; Masaki Hiruoka; Akiyoshi Hoshino; Noriyoshi Manabe; Yoshinobu Manome; Ryosuke Miyasaka; Keisuke Sato; Richard D Tilley; Kenji Yamamoto
Luminescent passive-oxidized silicon quantum dots as biological staining labels and their cytotoxicity effects at high concentration.
Nanotechnology 2008;19(41):415102.
2007: Hiroshi Takeyama; Tetsuo Hosoya; Noboru Shinozaki; Michiko Watanabe; Yoshinobu Manome; Hisashi Shioya; Satoki Kinoshita; Ken Uchida; Sadao Anazawa; Toshiaki Morikawa
Cytological and histological diagnoses of recurrent thyroid carcinoma with monoclonal antibody JT-95, which can detect modified fibronectin.
Pathology, research and practice 2007;203(7):507-15.
2006: Michiko Watanabe; Nobutake Akiyama; Hiroshi Sekine; Mariko Mori; Yoshinobu Manome
Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death.
Anticancer research 2006;26(5A):3421-7.
2006: Yoshinobu Manome; Toshiaki Kobayashi; Mariko Mori; Rie Suzuki; Naotake Funamizu; Nobutake Akiyama; Sachiko Inoue; Yasuhiko Tabata; Michiko Watanabe
Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
Anticancer research 2006;26(5A):3317-26.
2006: Hiromi Kojima; Minoru Iida; Yuichirou Yaguchi; Rie Suzuki; Norihiko Hayashi; Hiroshi Moriyama; Yoshinobu Manome
Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
Archives of otolaryngology--head & neck surgery 2006;132(6):682-5.
2005: Norihiro Hayashi; Koji Asano; Hideaki Suzuki; Tetsuhisa Yamamoto; Nobuhiko Tanigawa; Shin Egawa; Yoshinobu Manome
Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo.
The Prostate 2005;65(1):10-9.
2005: Michiko Watanabe; Nobutake Akiyama; Noriko Hasegawa; Yoshinobu Manome
Progressive degeneration of stereocilia in cochlear hair cells in hearing-impaired kuru2 mice.
In vivo (Athens, Greece) 2005;19(4):675-81.
2005: Yoshinobu Manome; Naoto Nakayama; Kiyoshi Nakayama; Hiroshi Furuhata
Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect.
Ultrasound in medicine & biology 2005;31(5):693-702.
2005: Minoru Iida; Hiromi Kojima; Hidemi Miyazaki; Yoshinobu Manome
Enhancement of cyclophosphamide sensitivity in squamous cell carcinoma transfected with cytochrome P-450 2B1.
American journal of otolaryngology 2005;26(1):22-7.
2003: Tetsuhisa Yamamoto; Yoshinobu Manome; Akiko Miyamoto; Nobuhiko Tanigawa
[Development of a novel gene therapy using survivin antisense expressing adenoviral vectors].
Gan to kagaku ryoho. Cancer & chemotherapy 2003;30(11):1805-8.
2003: Hisao Yoshinaga; Michiko Watanabe; Yoshinobu Manome
Possible role of nicaraven in neuroprotective effect on hippocampal slice culture.
Canadian journal of physiology and pharmacology 2003;81(7):683-9.
2003: Yoshinobu Manome; Natsumi Saeki; Hisao Yoshinaga; Michiko Watanabe; Shuichi Mizuno
A culture device demonstrates that hydrostatic pressure increases mRNA of RGS5 in neuroblastoma and CHC1-L in lymphocytic cells.
Cells, tissues, organs 2003;174(4):155-61.
2002: Tetsuhisa Yamamoto; Yoshinobu Manome; Motoyuki Nakamura; Nobuhiko Tanigawa
Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(17):2316-24.
2002: Noriko Hasegawa; Michiko Watanabe; Hideo Inoue; Takeshi Kobayashi; Hiromi Kojima; Yoshinobu Manome
Mutant ICR mouse, kuru2, manifests hearing impairment and abnormal behavior.
In vivo (Athens, Greece) 2002;16(5):349-60.
2002: Yoshinobu Manome; Hisao Yoshinaga; Michiko Watanabe; Tsuneya Ohno
Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea.
Anticancer research 2002;22(4):2029-36.
2002: Hiromi Kojima; Minoru Iida; Hidemi Miyazaki; Tomohiko Koga; Hiroshi Moriyama; Yoshinobu Manome
Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase.
Archives of otolaryngology--head & neck surgery 2002;128(6):708-13.
2001: Yoshinobu Manome; Michiko Watanabe; T Abe; M Tomita; S Watanabe; Y Yokokawa; Y Takahashi; K Ishii; A Kimura; M Murakami; M Nagata; T Shibata; M Nakamura; Nobuhiko Tanigawa; Tsuneya Ohno
Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Anticancer research 2001;21(4A):2265-72.
2000: Yoshinobu Manome; M Nakamura; Tsuneya Ohno; Hiroshi Furuhata
Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo.
Human gene therapy 2000;11(11):1521-8.
1999: Yoshinobu Manome; Michiko Watanabe; K Futaki; H Ishiguro; S Iwagami; K Noda; H Dobashi; Y Ochiai; Y Ohara; K Sanuki; T Kunieda; Tsuneya Ohno
Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyltransferase cDNA.
Anticancer research 1999;19(6B):5313-8.
1998: Yoshinobu Manome; T Kunieda; Patrick Y Wen; T Koga; Donald Kufe; Tsuneya Ohno
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
Human gene therapy 1998;9(10):1409-17.
1997: J Gong; L Chen; D Chen; M Kashiwaba; Yoshinobu Manome; T Tanaka; Donald Kufe
Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells.
Gene therapy 1997;4(10):1023-8.
1997: M J Parr; Yoshinobu Manome; T Tanaka; Patrick Y Wen; Donald Kufe; William G Kaelin; H A Fine
Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.
Nature medicine 1997;3(10):1145-9.
1997: T Tanaka; Yoshinobu Manome; Patrick Y Wen; Donald Kufe; H A Fine
Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.
Nature medicine 1997;3(4):437-42.
1996: Yoshinobu Manome; Patrick Y Wen; L Chen; T Tanaka; Y Dong; M Yamazoe; A Hirshowitz; Donald Kufe; H A Fine
Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide.
Gene therapy 1996;3(6):513-20.
1996: Yoshinobu Manome; Patrick Y Wen; Y Dong; T Tanaka; Beverly S Mitchell; Donald Kufe; H A Fine
Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo.
Nature medicine 1996;2(5):567-73.
1996: Y Dong; Patrick Y Wen; Yoshinobu Manome; M Parr; A Hirshowitz; L Chen; E A Hirschowitz; R Crystal; Ralph Weichselbaum; Donald Kufe; H A Fine
In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine.
Human gene therapy 1996;7(6):713-20.
1996: Y Emoto; H Kisaki; Yoshinobu Manome; S Kharbanda; Donald Kufe
Activation of protein kinase Cdelta in human myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
Blood 1996;87(5):1990-6.
1996: Yoshinobu Manome; X J Yao; Donald Kufe; E A Cohen; H A Fine
Selective effects of DNA damaging agents on HIV long terminal repeat activation and virus replication in vitro.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(2):109-16.
1995: Y Emoto; Yoshinobu Manome; G Meinhardt; H Kisaki; S Kharbanda; M Robertson; T Ghayur; Winnie W Wong; R Kamen; Ralph Weichselbaum
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
The EMBO journal 1995;14(24):6148-56.
1995: L Chen; D Chen; Yoshinobu Manome; Y Dong; H A Fine; Donald Kufe
Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.
The Journal of clinical investigation 1995;96(6):2775-82.
1995: Yoshinobu Manome; Patrick Y Wen; A Hershowitz; T Tanaka; Barrett J Rollins; Donald Kufe; H A Fine
Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
Cancer immunology, immunotherapy : CII 1995;41(4):227-35.
1995: Rakesh Datta; Yoshinobu Manome; N Taneja; Lawrence Boise; Ralph Weichselbaum; Craig Thompson; Christopher A Slapak; Donald Kufe
Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(4):363-70.
1994: Yoshinobu Manome; M Abe; M F Hagen; H A Fine; Donald Kufe
Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
Cancer research 1994;54(20):5408-13.
1993: Yoshinobu Manome; Rakesh Datta; N Taneja; T Shafman; E Bump; R Hass; Ralph Weichselbaum; Donald Kufe
Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation.
Biochemistry 1993;32(40):10607-13.
1993: Yoshinobu Manome; Rakesh Datta; H A Fine
Early response gene induction following DNA damage in astrocytoma cell lines.
Biochemical pharmacology 1993;45(8):1677-84.
1993: Yoshinobu Manome; R R Weichselbaum; Donald Kufe; H A Fine
Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells.
Oncology research 1993;5(3):139-44.
1989: Yoshinobu Manome; M Watanabe; T Ohno
The effect of immunotoxin against human glioma cells.
Neurochirurgia 1989;32(5):146-9.